Cancer progression can be spurred by TGF-beta pathway signaling, and Michigan Medicine researchers have found a way to stop the signal from turning green.
Rosemary (Rosie) Clandos is a contributing health and science writer. She has written for the Los Angeles Times, Kaiser Permanente, U.S. Department of Defense, National Science Foundation, and several universities and medical centers on the West Coast. Rosie has covered topics ranging from medicine to microelectromechanical systems. As the author of “Health Hunt on the Internet: Find and Use Reliable Medical Information,” she specializes in compelling storytelling.
Michigan Medicine experts discuss whether active surveillance — close monitoring without immediate treatment — could reduce overtreatment for some thyroid, prostate and breast cancer patients.
In New York state, mandated physician-patient communication helped some cancer patients get a beneficial procedure. But more work is needed to narrow treatment gaps.
To improve local tumor control in advanced nonsmall cell lung cancer, a midtreatment PET-CT scan can detect active tumors for escalated radiation, new research finds.
For the first time, researchers have found an important factor that mitigates immune suppression in cancer.